News

“Most users tolerate GLP-1 medications like Ozempic without serious oral health issues, but a subset experience notable side ...
Amanda Bynes is showing off her new look, revealing to her followers that she recently received lip injections to plump up ...
Serena Williams' suggestion that injectable weight loss drugs could have helped her in tennis is part of an ongoing ...
For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy.
Gary Winslett is an associate professor at Middlebury College in Vermont. By now, you’ve probably heard about the weight-loss benefits of GLP-1 drugs like Ozempic (semaglutide) and Mounjaro ...
For adults with diabetes, semaglutide treatment is not associated with increased risk of eye disorders or diabetic retinopathy.
In patients with type 2 diabetes (T2D), treatment with oral semaglutide demonstrated a modest but significant reduction in ...
Novo Nordisk Earnings: CVS Deal, Oral Semaglutide Support Growth Despite Compounding Uncertainty We think Novo Nordisk stock is undervalued.
Novo Nordisk is committed to the responsible use of our semaglutide-containing medicines which represent distinct products with different indications, dosages, prescribing information, titration ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those with previous adverse reactions.
‘Miracle’ drugs used for weight-loss like Semaglutide and Tirzepatide—better known by their brand names Ozempic and Mounjaro—are unlikely to stop people from eating. Not because they don't ...